105 related articles for article (PubMed ID: 19624899)
21. Prognostic factors and long term results of neo adjuvant therapy followed by surgery in stage IIIA N2 non-small cell lung cancer patients.
Li J; Dai CH; Shi SB; Chen P; Yu LC; Wu JR
Ann Thorac Med; 2009 Oct; 4(4):201-7. PubMed ID: 19881166
[TBL] [Abstract][Full Text] [Related]
22. Survival Analysis in Single N2 Station Lung Adenocarcinoma: The Prognostic Role of Involved Lymph Nodes and Adjuvant Therapy.
Chiappetta M; Lococo F; Leuzzi G; Sperduti I; Bria E; Petracca Ciavarella L; Mucilli F; Filosso PL; Ratto G; Spaggiari L; Facciolo F; Margaritora S
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809513
[TBL] [Abstract][Full Text] [Related]
23. Lymph node metastasis and its risk factors in T1 lung adenocarcinoma.
Zhang W; Mu G; Huang J; Bian C; Wang H; Gu Y; Xia Y; Chen L; Yuan M; Wang J
Thorac Cancer; 2023 Oct; 14(30):2993-3000. PubMed ID: 37667435
[TBL] [Abstract][Full Text] [Related]
24. Nodal Involvement Pattern in Clinical Stage IA Non-Small Cell Lung Cancer According to Tumor Location.
Meng S; Liu G; Wang S; Yang F; Wang J
Cancer Manag Res; 2020; 12():7875-7880. PubMed ID: 32904622
[TBL] [Abstract][Full Text] [Related]
25. Metastatic potential of T1a and T1b non-small cell lung cancer: analysis in the Czech population.
Tulinský L; Kepičová M; Mitták M; Martínek L
Rozhl Chir; 2023; 102(6):244-250. PubMed ID: 38286653
[TBL] [Abstract][Full Text] [Related]
26. Effect of Surgical Treatment for N2-Positive c-stage III Non-Small Cell Lung Carcinoma in the "PACIFIC" Era.
Adachi H; Ito H; Isaka T; Murakami K; Miura J; Kikunishi N; Shigeta N; Saito H; Yoshida D; Yokose T; Saito A
Clin Lung Cancer; 2023 Dec; 24(8):733-742. PubMed ID: 37543472
[TBL] [Abstract][Full Text] [Related]
27. Immune characteristics associated with lymph node metastasis in early-stage NSCLC.
Zhang Z; Li L; Gao Y; Xiao X; Ji L; Zhou Z; Jiang J; Liu S; An J; Deng P; Du N; Li P; Xia X; Hu C; Li M
Cell Oncol (Dordr); 2024 Apr; 47(2):447-461. PubMed ID: 37728859
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for lymph node metastasis and surgical scope in patients with cN0 non-small cell lung cancer: a single-center study in China.
Jianlong B; Pinyi Z; Xiaohong W; Su Z; Sainan P; Jinfeng N; Shidong X
J Cardiothorac Surg; 2021 Oct; 16(1):304. PubMed ID: 34663403
[TBL] [Abstract][Full Text] [Related]
29. Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials.
Wright G; Manser RL; Byrnes G; Hart D; Campbell DA
Thorax; 2006 Jul; 61(7):597-603. PubMed ID: 16449262
[TBL] [Abstract][Full Text] [Related]
30. Recurrence/prognosis estimation using a molecularly positive surgical margin-based model calls for alternative curative strategies in pIIIA/N2 NSCLC.
Li L; He K; Zhou T; Xu Y; Pang J; Yu Q; Gao Y; Shi H; Zhu H; Li M; Yu J; Yuan S
Mol Oncol; 2024 Jun; 18(6):1649-1664. PubMed ID: 38327028
[TBL] [Abstract][Full Text] [Related]
31. Operative versus Nonoperative Treatment in Patients with Advanced Non-Small-Cell Lung Cancer: Recommended for Surgery.
Wang H; Yang D; Lv Y; Lin J; Wang H
Can Respir J; 2023; 2023():4119541. PubMed ID: 36687390
[TBL] [Abstract][Full Text] [Related]
32. Enhancing Patient Selection in Stage IIIA-IIIB NSCLC: Invasive Lymph Node Restaging after Neoadjuvant Therapy.
Kwiatkowski R; Zieliński M; Paluch J; Gabor J; Swinarew A
J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256555
[TBL] [Abstract][Full Text] [Related]
33. Quality control of postoperative radiotherapy for non-small cell lung cancer: A study of mediastinal shift.
Zhang W; Zhang Y; Ouyang WW; Fa Su S; Ma Z; Li QS; Gang Yang W; Xia Chen X; Liu J; Lu B
Cancer Radiother; 2024 Apr; 28(2):152-158. PubMed ID: 38320903
[TBL] [Abstract][Full Text] [Related]
34. Occult lymph node metastasis is not a favorable factor for resected NSCLC patients.
Cai JS; Yang F; Wang X
BMC Cancer; 2023 Sep; 23(1):822. PubMed ID: 37667180
[TBL] [Abstract][Full Text] [Related]
35. [Clinical characteristics and prognosis analysis of 17 cases of SMARCA4-deficient chest tumors].
Cao XN; Li Z; Wang QY
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):325-331. PubMed ID: 38599807
[No Abstract] [Full Text] [Related]
36. Intraoperative Versus Preoperative Diagnosis of Lung Cancer: Differences in Treatments and Patient Outcomes.
Mack SJ; Collins ML; Whitehorn GL; Till BM; Grenda TR; Evans NR; Okusanya OT
Clin Lung Cancer; 2023 Dec; 24(8):726-732. PubMed ID: 37479586
[TBL] [Abstract][Full Text] [Related]
37. ASO Author Reflections: Upfront Surgery Followed by Adjuvant Therapy: An Option for IIIA-N2 Non-small Cell Lung Cancer.
Fu F; Zhang Y; Chen H
Ann Surg Oncol; 2023 Dec; 30(13):8284. PubMed ID: 37755561
[No Abstract] [Full Text] [Related]
38. Upfront surgery for N2 NSCLC: a large retrospective multicenter cohort study.
Campisi A; Catelli C; Gabryel P; Giovannetti R; Dell'Amore A; Kasprzyk M; Piwkowski C; Infante M
Gen Thorac Cardiovasc Surg; 2023 Dec; 71(12):715-722. PubMed ID: 37179506
[TBL] [Abstract][Full Text] [Related]
39. Metastatic pathways to the lower zone by segment in patients with clinical T1 lower lobe non-small cell lung cancer.
Maniwa T; Ohue M; Kanzaki R; Shintani Y; Okami J
Gen Thorac Cardiovasc Surg; 2024 Mar; ():. PubMed ID: 38498143
[TBL] [Abstract][Full Text] [Related]
40. Surgical resection and survival of patients with unsuspected single node positive lung cancer (NSCLC) invading the descending aorta.
Wex P; Graeter T; Zaraca F; Haas V; Decker S; Bugdayev H; Ebner H
Thorac Surg Sci; 2009 Jul; 6():Doc02. PubMed ID: 21289904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
